Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines (Q39451100)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines |
scientific article |
Statements
1 reference
Blocking the PI3K/AKT and MEK/ERK signaling pathways can overcome gefitinib-resistance in non-small cell lung cancer cell lines (English)
1 reference
H Li
1 reference
G Schmid-Bindert
1 reference
D Wang
1 reference
Y Zhao
1 reference
X Yang
1 reference
B Su
1 reference
C Zhou
1 reference
1 January 2011
1 reference
1 reference
Identifiers
1 reference